{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:01:03Z","timestamp":1791414063631,"version":"4.3.3"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejogrb.2017.12.033","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T02:38:04Z","timestamp":1513651084000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Outcome of patients with uterine fibroids after 3-month ulipristal acetate therapy"],"prefix":"10.1016","volume":"222","author":[{"given":"Jean-Luc","family":"Brun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Rajaonarison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliz\u00e9e","family":"Froeliger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Coline","family":"Monseau-Thiburce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rado","family":"Randriamboavonjy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Vogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2017.12.033_bib0005","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jgyn.2014.07.006","article-title":"Prevalence of uterine fibroids in France and impact on quality of life: results of a survey among 2500 women between 30 and 55 years","volume":"43","author":"Fernandez","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejogrb.2012.07.030","article-title":"CNGOF (French College of Gynecology and Obstetrics): Therapeutic management of uterine fibroid tumors: updated French guidelines","volume":"165","author":"Marret","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"PEARL I Study Group: ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"PEARL II Study Group: ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0025","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"PEARL III and PEARL III extension study group: long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fertnstert.2014.10.038","article-title":"Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids","volume":"103","author":"Donnez","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0035","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/uog.14668","article-title":"Influence of ulipristal acetate therapy compared with uterine artery embolization on fibroid volume and vascularity indices assessed by three-dimensional ultrasound: prospective observational study","volume":"45","author":"Czuczwar","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0040","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.fertnstert.2016.06.012","article-title":"Role of ethnicity in treating uterine fibroids with ulipristal acetate","volume":"106","author":"Murji","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejogrb.2016.11.003","article-title":"Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: premya study results","volume":"208","author":"Fernandez","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0050","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.fertnstert.2011.03.079","article-title":"The FIGO classification of causes of abnormal uterine bleeding in the reproductive years","volume":"95","author":"Munro","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0055","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/biomet\/60.2.255","article-title":"Maximum likelihood identification of Gaussian autoregressive moving average models","volume":"60","author":"Akaike","year":"1973","journal-title":"Biometrika"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejogrb.2016.08.021","article-title":"Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study","volume":"205","author":"Ferrero","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0301-2115(03)00075-7","article-title":"Cytogenetic analysis of uterine leiomyoma: the size, histopathology and GnRHa response in relation to chromosome karyotype","volume":"110","author":"Kataoka","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0075","first-page":"3","article-title":"Natural history of uterine polyps and leiomyomata","volume":"100","author":"Dewaay","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0080","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal black and white women","volume":"105","author":"Peddada","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0085","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0015-0282(16)58503-3","article-title":"Analysis of the karyotype and desoxyribonucleic acid content of uterine myomas in premenopausal, menopausal, and gonadotropin releasing hormone agonist treated females","volume":"66","author":"Brosens","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0090","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.fertnstert.2015.04.024","article-title":"Increased progesterone receptor expression in uterine leiomyoma: correlation with age, number of leiomyomas, and clinical symptoms","volume":"104","author":"Tsigkou","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0095","first-page":"357","article-title":"Myomectomy: technique and current indications","volume":"69","author":"Rakotomahenina","year":"2017","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0100","first-page":"414","article-title":"Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma","volume":"83","author":"Parker","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jmig.2016.08.004","article-title":"Unexpected uterine leiomyosarcoma during laparoscopic hysterectomy treated 6 months with ulipristal acetate and contained power morcellation","volume":"24","author":"Istre","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0110","first-page":"1","article-title":"Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review","volume":"21","author":"Modaffari","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0115","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jogoh.2017.06.002","article-title":"Borja De Mozota D. Inefficiency of ulipristal acetate on uterus leiomyomas as an additional sign to suspect leiomyosarcoma","volume":"46","author":"Kadhel","year":"2017","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0120","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0015-0282(16)54001-1","article-title":"Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 women","volume":"54","author":"Vollenhoven","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejogrb.2015.05.022","article-title":"Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist","volume":"191","author":"Yun","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0130","doi-asserted-by":"crossref","first-page":"436174","DOI":"10.1155\/2012\/436174","article-title":"Effect of a selective progesterone receptor modulator on induction of apoptosis in uterine fibroids in vivo","volume":"2012","author":"Horak","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.ejogrb.2017.12.033_bib0135","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2015.04.025","article-title":"In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment","volume":"104","author":"Courtoy","year":"2015","journal-title":"Fertil Steril"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517305833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517305833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T19:26:57Z","timestamp":1721330817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211517305833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":27,"alternative-id":["S0301211517305833"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.12.033","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of patients with uterine fibroids after 3-month ulipristal acetate therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}